02/07/2025 - General information
Levels of butyrate and isobutyrate, short-chain fatty acids produced by the gut microbiota, are associated with a higher risk of developing the disease, according to a study led by IISPV and Hospital del Mar. A research team led by scientists from the Pere Virgili Health Research Institute (IISPV), the Hospital del Mar Research Institute, and the Diabetes and Associated Metabolic Diseases area of the CIBER (CIBERDEM) has identified two compounds present in the blood - butyrate and isobutyrate - that could serve as early predictors of type 2 diabetes in seemingly healthy individuals.
30/06/2025 - General information
The Health Services Research Group at the Hospital del Mar Research Institute of Barcelona (HMRIB) is leading the INSTRUMENTAL project, in collaboration with the General Subdirectorate of Addictions, HIV and Viral Hepatitis (SGAVIHV). The project aims to generate relevant and applicable knowledge about the mental health measurement instruments used in general population studies. This pioneering initiative seeks to optimize how population mental health is assessed.
27/06/2025 - Press release
A study by the Hospital del Mar Research Institute, recently published in the journal PNAS, advances our understanding of how the brain makes decisions by participating in the storage of associations between different stimuli. The research has identified the importance of specific brain areas in these processes, particularly the amygdala and its relationship with parts of the cerebral cortex. This finding could lead to new therapeutic approaches for treating mental disorders such as psychosis or post-traumatic stress disorder (PTSD). The study was conducted on mice, but the researchers believe that the mechanisms involved may be similar in humans.
Més informació "Understanding How the Brain Makes Decisions"
27/06/2025 - General information
Dr. Alicia Prieto, researcher at the Heart Disease Research Group of the Hospital del Mar Research Institute of Barcelona (HMRIB) and cardiologist at Hospital del Mar, has been awarded one of the three Daniel Bravo Foundation Fellowships to carry out advanced research in cardiology at leading international centers, including the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).
20/06/2025 - Press release
People with Chronic Obstructive Pulmonary Disease (COPD) who suffer from sarcopenia, or loss of muscle capacity, have higher levels of a protein called myostatin, which, under normal conditions, helps regulate muscle growth. Elevated levels of this protein trigger a series of reactions in the muscle cells, preventing regeneration and growth after damage, leading to muscle mass loss in these patients. This was revealed by a study from the Hospital del Mar and the Hospital del Mar Research Institute, which opens the door to developing treatments targeted at this protein to reverse this situation.
Més informació "Researchers Discover the Cause of Muscle Loss in Some COPD Patients"
16/06/2025 - General information
The Head of the Gastrointestinal Surgery Unit of the General Surgery Department and researcher at the Hospital del Mar Research Institute had been a corresponding academic since 2024. On June 15, Dr. Manuel Pera, Head of the Gastrointestinal Surgery Unit at Hospital del Mar and researcher at its research institute, was appointed as a full academic member of the Royal Academy of Medicine of Catalonia. He now becomes one of the sixty full academic members of the institution, replacing Professor Lluís Morales i Fochs. The ceremony was sponsored by Professor Carmen Gomar and Professor Laureano Fernández-Cruz.
Més informació "Dr. Manuel Pera is now a full member of the Royal Academy of Medicine of Catalonia"
06/06/2025 - Press release
Following a diet based on Mediterranean diet recommendations and engaging in moderate physical activity is associated with a 41% to 59% lower risk of starting antidepressant, anxiolytic, antipsychotic, and antiseizure medications. The study is published in the journal Age and Ageing and is based on data from the PREDIMED study, a clinical trial on the effects of the Mediterranean diet in the prevention of cardiovascular disease. The analysis includes data from between 6,000 and 7,000 participants in the study, all older adults at risk for chronic illness.
10/06/2025 - General information
The Spanish Society of Neurology has awarded the scientific career of the coordinator of the Multiple Sclerosis Unit at Hospital del Mar and the coordinator of the Neuroimmunology Research Group at its research institute. Dr. José Enrique Martínez received the 'Premio SEN Esclerosis Múltiple' on June 4th, during the Institutional Ceremony of the Spanish Society of Neurology, recognizing his scientific work in this field. These awards represent the SEN's recognition of individuals or entities that have contributed to the development of neurology.
Més informació "SEN Multiple Sclerosis Award for Dr. José Enrique Martínez"
06/06/25 - Press release
Having high blood levels of a type of molecule, spermidine, before surgery increases the risk of tumor recurrence after surgery by 4.7 times. This risk decreases if spermidine levels in the patient's blood drop after surgery. The study is published in the Annals of Surgery journal and opens the door to determining which individuals are at higher risk, either before entering the operating room or just afterward, in order to offer them complementary or specific treatment.
27/05/2025 - Press release
A joint project between the three research institutions has been selected for funding by the XPRIZE Foundation of the United States. It will receive $250,000 to demonstrate that it is possible to extend human healthy lifespan. The VITA project proposes combining two existing molecules and a multimodal lifestyle intervention to extend quality of life during aging. The team formed by the three institutions now has one year to provide the first preliminary results and move on to a new stage of the awards, where the efficacy of the proposed new therapy will be assessed.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
